Stay updated on Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed information about a clinical trial for liver cancer treatment and the addition of new collaborators and registry identifiers. The revision number has also been updated.SummaryDifference34%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 7, 2025. However, there are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of February 7, 2025.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe webpage has updated its last update dates to reflect new information for February 2025, while removing previous dates from October 2024. Additionally, there is a notice regarding heavy traffic affecting some services.SummaryDifference1%
Stay in the know with updates to Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.